Skip to content

US · SLSN · HOUSEHOLD & PERSONAL PRODUCTS

Solesence, Inc. Common Stock (SLSN) intrinsic value and stock valuation

$1.41as of 2026-11-21 · Mkt cap 75.58M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Solesence, Inc. Common Stock DCF and intrinsic value

InvestorsCraft values SLSN with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from SLSN’s statements →

Solesence, Inc. Common Stock Graham Number

Graham Number: $0.38d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Consumer Defensive · Household & Personal Products Romeoville, IL 60446 solesence.com

How the business is doing

Fiscal 2021–2025, USD

Revenue
$62.1M
20212025
Net income
$1.79M
20212025
Free cash flow
-$-10.71M
20212025
Total equity
$17.6M
20212025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$62.1M$52.4M$37.3M$37.3M$29.5M
Operating income$1.57M$5.13M-$-3.55M-$-2.26M$2.56M
Net income$1.79M$4.24M-$-4.39M-$-2.62M$2.32M
EPSd$24.7K$65.2K-$-88.58K-$-53.34K$49.3K
Operating cash flow-$-8.57M$1.97M-$-2.01M-$-1.65M$2.32M
Capital expenditure-$-2.14M-$-4.56M-$-1.05M-$-2.82M-$-1.87M
Free cash flow-$-10.71M-$-2.59M-$-3.06M-$-4.47M$450K
Total assets$50.1M$50M$32.9M$33.6M$28.4M
Total debt$24.3M$15.3M$21.3M$18.1M$14.8M
Net debt$23M$13.9M$19.5M$15.9M$14.1M
Total equity$17.6M$15M$1.9M$5.65M$7.46M
Cash and short-term investments$1.29M$1.41M$1.72M$2.19M$660K
Income statement
20252024202320222021
Revenue$62.1M$52.4M$37.3M$37.3M$29.5M
Cost of revenue$46M$36.2M$29.5M$29M$20.8M
Gross profit$16M$16.2M$7.83M$8.36M$8.69M
Research and development expenses$4.08M$3.84M$3.84M$3.04M$2.23M
Selling, general and administrative expenses$10.4M$7.22M$7.53M$7.58M$3.9M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$14.5M$11.1M$11.4M$10.6M$6.13M
Cost and expenses$60.5M$47.2M$40.8M$39.6M$26.9M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$930K$670K$840K$380K$1.15M
Depreciation and amortization$900K$930K$740K$570K$450K
Ebitda$3.69M$6.06M-$-2.8M-$-1.69M$3.96M
Operating income$1.57M$5.13M-$-3.55M-$-2.26M$2.56M
Total other income/expenses, net$290K-$-670K-$-840K-$-380K-$-200K
Income before tax$1.86M$4.46M-$-4.38M-$-2.64M$2.36M
Income tax expense$70K$230K$10K-$-20K$40K
Net income$1.79M$4.24M-$-4.39M-$-2.62M$2.32M
Weighted average shares outstanding$70.3M$62.4M$49.6M$49.1M$45M
Weighted average diluted shares outstanding$72.6M$65M$49.6M$49.1M$47M
Balance sheet
20252024202320222021
Cash and short-term investments$1.29M$1.41M$1.72M$2.19M$660K
Net receivables$6.84M$4.87M$3.47M$4.73M$3.94M
Inventory$18.5M$20.3M$10M$8.84M$6.09M
Total current assets$28.8M$29.4M$16.3M$16.6M$11.6M
Property, plant and equipment, net$6.91M$20.7M$16.6M$16.9M$16.8M
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$21.3M$20.7M$16.6M$16.9M$16.8M
Total assets$50.1M$50M$32.9M$33.6M$28.4M
Accounts payable$4.39M$10.7M$6.39M$6.77M$3.89M
Short-term debt$6.02M$6.26M$6.11M$4.28M$2.04M
Deferred revenue$930K$5.57M$2.35M$2.23M$910K
Total current liabilities$13.9M$25.8M$15.6M$13.8M$7.34M
Long-term debt$18.3M$9.04M$15.2M$13.8M$12.7M
Deferred revenue, non-current$0.00$0.00$0.00$20K$660K
Total non-current liabilities$18.5M$9.28M$15.4M$14.1M$13.6M
Capital lease obligations$9.05M$10.3M$10.5M$9.82M$12.4M
Total liabilities$32.4M$35.1M$31M$27.9M$20.9M
Common stock$710K$700K$500K$490K$490K
Retained earnings-$-98.64M-$-100.43M-$-104.66M-$-100.07M-$-97.45M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$17.6M$15M$1.9M$5.65M$7.46M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$24.3M$15.3M$21.3M$18.1M$14.8M
Net debt$23M$13.9M$19.5M$15.9M$14.1M
Cash flow statement
20252024202320222021
Net income$1.79M$4.24M-$-4.39M-$-2.62M$2.32M
Depreciation and amortization$900K$930K$740K$570K$450K
Stock-based compensation$570K$720K$770K$620K$160K
Change in working capital-$-11.83M-$-3.92M$870K-$-2.79M-$-560K
Accounts receivable-$-1.97M-$-1.4M$1.06M-$-800K-$-1M
Inventory$1.76M-$-10.24M-$-1.19M-$-2.74M-$-1.75M
Accounts payable-$-5.38M$2.4M-$-500K$0.00$1.03M
Net cash provided by operating activities-$-8.57M$1.97M-$-2.01M-$-1.65M$2.32M
Investments in property, plant and equipment-$-2.14M-$-4.56M-$-1.05M-$-2.82M-$-1.87M
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-2.14M-$-4.56M-$-1.05M-$-2.82M-$-1.87M
Common stock issued$320K$0.00$0.00$180K$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$10.6M$2.27M$2.59M$6M-$-750K
Net change in cash-$-120K-$-310K-$-460K$1.53M-$-300K
Cash at end of period$1.29M$1.41M$1.72M$2.19M$660K
Operating cash flow-$-8.57M$1.97M-$-2.01M-$-1.65M$2.32M
Capital expenditure-$-2.14M-$-4.56M-$-1.05M-$-2.82M-$-1.87M
Free cash flow-$-10.71M-$-2.59M-$-3.06M-$-4.47M$450K
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Solesence, Inc. Common Stock

        Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.

        CEO
        Kevin Cureton
        Employees
        115
        Beta
        1.31

        Explore

        Frequently asked questions

        What is the intrinsic value of Solesence, Inc. Common Stock (SLSN)?

        InvestorsCraft does not currently publish an intrinsic value for SLSN. How the IC value is calculated.

        Is SLSN undervalued?

        InvestorsCraft does not publish an undervaluation signal for SLSN at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.